20
Centrient Pharmaceuticals Netherlands B.v. Delft Nl, based in Gabon, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Cefprozil monohydrate, Powder and compacted, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2017-301 - Rev 00
This Chemical Type CEP, issued on June 06, 2019, remains in force until March 01, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 2342 associated with this CEP further emphasizes